IMMUNITYBIO, INC.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $712.8M | $468.9M | $181.1M |
| FY2022 | $812.2M | $362.4M | $104.6M |
| FY2023 | $1.09B | $504.5M | $265.5M |
| FY2024 | $871.1M | $382.9M | $143.4M |
| FY2025 | $1.00B | $501.9M | $88.3M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2021 | $712.8M | $468.9M | $181.1M |
| FY2022 | $812.2M | $362.4M | $104.6M |
| FY2023 | $1.09B | $504.5M | $265.5M |
| FY2024 | $871.1M | $382.9M | $143.4M |
| FY2025 | $1.00B | $501.9M | $88.3M |